New (S)-verbenone-isoxazoline-1,3,4-thiadiazole Hybrids: Synthesis, Anticancer Activity and Apoptosis-Inducing Effect

Abstract

These findings underscore the potential of (S)-verbenone isoxazoline-1,3,4-thiadiazole derivatives for breast cancer therapy due to their remarkable apoptotic activity. This study highlights a promising avenue for advancing breast cancer treatment using these derivatives, founded on (S)-verbenone, showcasing their distinct potential for inducing apoptosis.